To confirm the results generated by microarray, we measured the levels of CD160 expression on CMV and HIV-specific CD8 T cells as well as total CD8 T cells isolated from 7 HIV-uninfected individuals and 38 HIV-infected subjects divided into 4 groups: acute HIV infection (AHI; n = 7), chronic/progressing infection (CHI; n = 9), successfully treated and aviremic individuals (ST; n = 12) and Elite controllers (ECs; n = 10) (Table 1, 2). The gene discussed is CD160; the disease is infection.